Latest Corporate News ; Pharma... Feb 01
In 2018, the FDA approved LORBRENA for the treatment of patients with ALK-positive metastatic NSCLC whose disease has progressed on crizotinib and at least ... Mar 05
The FDA grants orphan drug designation to drugs and biologics that are intended for the treatment of rare diseases that affect fewer than 200,000 ... Dec 30
INP104 is indicated in treatment of acute migraine... Nov 10
CPI-613(devimistat) is indicated for the treatment of soft tissue sarcoma... Oct 31
Lupin launches generic version of Novartis's Tykerb Tablets... Sep 30
... Sep 23
-Advertisements-